北京商报讯（记者 刘宇阳 实习生 姚榕琰）1月6日，南京证券发布公告称，公司总工程师江念南因到龄退休离任，离任日期为1月6日。 公告显示，江念南的原定任期到期日为10月11日，离任后不继续在上市公司及其控股子公司任职，其离任不会影响公司的正常经营。 ...

Group 1 - The Qingdao Securities Regulatory Bureau announced that the client development business of Hengtai Futures Co., Ltd. Qingdao Branch was essentially outsourced, leading to significant deficiencies in internal control and risk management [1] - The situation was found to violate ongoing operational rules, severely jeopardizing the institution's stable operation and harming the legal rights of traders [1] - A notice was sent to Hengtai Futures Qingdao Branch on December 23, 2025, regarding corrective measures and a three-month suspension of new client accounts for futures brokerage business [1] Group 2 - Hengtai Futures Qingdao Branch was required to correct the identified issues within 30 working days from the receipt of the decision and submit a rectification report [1] - During the suspension period, the branch must maintain and service existing clients while conducting a comprehensive overhaul of internal controls and compliance risk management [1] - New client account openings can only resume after the suspension period ends and the branch passes the inspection and acceptance by the Qingdao Securities Regulatory Bureau [1]

此外，公司董事会同意聘任李捷为公司总经理，任期自本次董事会审议通过之日起至第十届董事会任期 届满之日止。 北京商报讯（记者 李晗）2026年1月6日，首开股份发布公告称，赵龙节因工作调整原因，申请辞任公 司总经理职务。根据上级党委决定，赵龙节转任公司党委书记。赵龙节将继续担任公司董事、董事会战 略与投资委员会委员职务。 ...

Core Viewpoint - The company Jia Mei Packaging announced a stock suspension for investigation due to significant price fluctuations, with a stock price increase of 230.48% from December 17, 2025, to January 6, 2026, leading to a market capitalization of 14.8 billion yuan as of January 6, 2026 [1][1][1] Group 1 - The company's stock will be suspended from trading starting January 7, 2026, for a period not exceeding three trading days [1] - The stock price reached 15.07 yuan per share at the close on January 6, 2026, with a total market value of 14.8 billion yuan [1][1] - The company stated that the recent stock price surge is not aligned with its fundamental business, which remains focused on the research, design, production, and sales of food and beverage packaging containers, as well as beverage filling services [1][1][1] Group 2 - There are no plans for significant changes to the company's main business or any major adjustments within the next 12 months [1] - The company does not plan to sell, merge, or collaborate with others regarding its assets or business in the next 12 months [1] - There are no plans for a reverse merger within the next 36 months [1]

Core Viewpoint - The announcement from the Bank of China regarding the resignation of Zhao Rong as the Chief Risk Officer due to job relocation, effective January 6, 2026, indicates a significant leadership change within the bank's risk management team [1]. Group 1: Resignation Announcement - Zhao Rong has submitted her resignation and will no longer serve as the Chief Risk Officer starting January 6, 2026 [1]. - Zhao Rong confirmed that there are no disagreements with the board and no other matters to notify shareholders [1]. - The necessary handover procedures have been completed as per the relevant requirements [1].

北京商报讯(记者孟凡霞周义力)1月6日，南平金融监管分局发布的一则行政处罚信息公示表显示，松溪 县农村信用合作联社因"违规审批发放贷款并形成案件；违规设置时点考核指标；员工行为管理不到 位；向无实际经营主体发放个人经营性贷款"违法违规行为，被合计处以150万元罚款，相关责任人季秋 才被给予警告并处以5万元罚款。 ...

北京商报讯（记者 丁宁）1月6日晚间，亚辉龙（688575）发布公告称，公司于近日与深圳脑机星链科 技有限公司（以下简称"脑机星链"）签署了《战略合作框架协议》，双方共同达成战略合作，通过整合 脑机接口技术与临床和市场资源，共同开发脑机接口相关在研产品及推进后续市场拓展及推广，提升在 中枢神经疾病等领域诊疗技术水平。 亚辉龙表示，脑机星链是一家以人工智能为核心驱动力，深耕非侵入式与侵入式双技术路径的脑机接口 领域企业，通过脑机接口应用平台(神经解码软件、超柔性多通道电极、应用芯片)与神经调控技术深度 结合，加速阿尔茨海默症、孤独症、抑郁症、脑疾病神经类疾病检测与诊断产品落地，形成横跨硬件终 端、算法模型与云端服务的三位一体架构。目前已开发有脑电采集分析仪、脑机接口助眠仪、脑机接口 睡眠监测仪、迷走神机刺激仪等产品。本次战略合作，将结合双方的优势，有利于提升公司在中枢神经 疾病等领域竞争力以及拓展公司在脑机接口相关领域的战略布局，符合公司长远发展战略和全体股东的 利益。 ...

交易行情显示，三博脑科于1月5日—6日连续两个交易日涨停，截至1月6日收盘，三博脑科报84.94元/ 股，涨幅为20.01%。 三博脑科表示，公司是以神经专科为特色的医疗服务集团，下属院区主要为患者提供以高精尖神经外科 为主的综合医疗服务。公司目前不涉及脑机接口产品的研发、生产及销售，神经调控技术带来的收入占 公司营业收入比重很小，对公司业绩基本没有影响。 北京商报讯（记者 丁宁）1月6日晚间，连续两个交易日涨停的三博脑科（301293）发布公告称，公司 股票于1月5日、1月6日，连续2个交易日内日收盘价格涨幅偏离值累计超过30%，根据《深圳证券交易 所交易规则》的规定，属于股票交易异常波动的情形。 ...

Group 1 - The core point of the article is that Xiangyu Medical (688626) has experienced a significant stock price fluctuation, with a cumulative increase of 30% over three consecutive trading days, triggering an abnormal trading alert according to stock exchange regulations [1] - The recent surge in interest in brain engineering and brain-computer interface concepts has positively impacted the stock prices in this sector, including Xiangyu Medical, which focuses on non-invasive brain-computer interface technology [1] - Xiangyu Medical's current technology and product development in brain-computer interfaces cover various rehabilitation scenarios, but the company acknowledges that its products are not expected to achieve large-scale sales until the end of 2025, resulting in a small revenue contribution at this time [1] Group 2 - The stock price of Xiangyu Medical reached a closing price of 87.12 yuan per share on January 6, with a 20% increase on that day, following two consecutive days of trading limits [1]

国晟科技表示，公司股价累计涨幅偏离基本面，存在市场情绪过热、非理性炒作风险，存在股价短期快 速回落风险。公司主营业务未发生变化，且处于亏损状态，对外投资的推进实施存在不确定性，收购股 权尚无实质性进展。公司存在控股股东股份质押比例较高的风险。 公告显示，2025年10月31日至2026年1月6日期间，公司股票5次触及股价异常波动、1次触及严重异常波 动情形，期间累计涨幅高达370.2%。 北京商报讯（记者 马换换 李佳雪）1月6日晚间，国晟科技（603778）披露公告称，公司将就股票交易 波动情况进行核查，公司股票将于1月7日起停牌，自披露核查公告后复牌。 ...